Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Abstract

Plasminogen activator inhibitor type 1 (PAI-1) plays a key role in tumor progression and is believed to control proteolytic activity and cell migration during angiogenesis. We report here that host PAI-1, at physiological concentration, promotes in vivo tumor invasion and angiogenesis. In sharp contrast, inhibition of tumor vascularization was observed when PAI-1 was produced at supraphysiologic levels, either by host cells (transgenic mice overexpressing PAI-1) or by tumor cells (after transfection with murine PAI-1 cDNA). This study provides for the first time in vivo evidence for a dose-dependent effect of PAI-1 on tumor angiogenesis. Of great interest is the finding that PAI-1 produced by tumor cells, even at high concentration, did not overcome the absence of PAI-1 in the host, emphasizing the importance of the cellular source of PAI-1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Almholt K, Nielsen BS, Frandsen TL, Brunner N, Dano K and Johnsen M . (2003). Oncogene, 22, 4389–4397.

  • Andreasen PA, Egelund R and Petersen HH . (2000). Cell Mol. Life Sci., 57, 25–40.

  • Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM and Noel A . (2001). J. Cell Biol., 152, 777–784.

  • Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D and Foidart JM . (1998). Nat. Med., 4, 923–928.

  • Curino A, Mitola DJ, Aaronson H, McMahon GA, Raja K, Keegan AD, Lawrence DA and Bugge TH . (2002). Oncogene, 21, 8830–8842.

  • Czekay RP, Aertgeerts K, Curriden SA and Loskutoff DJ . (2003). J. Cell Biol., 160, 781–791.

  • Deng G, Curriden SA, Hu G, Czekay RP and Loskutoff DJ . (2001). J. Cell Physiol., 189, 23–33.

  • Deng G, Curriden SA, Wang S, Rosenberg S and Loskutoff DJ . (1996). J. Cell Biol., 134, 1563–1571.

  • Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Noel A and Foidart JM . (2002). FASEB J., 16, 147–154.

  • Eitzman DT, Krauss JC, Shen T, Cui J and Ginsburg D . (1996). Blood, 87, 4718–4722.

  • Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brunner N, Janicke F, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WL and Klijn JG . (2000). Cancer Res., 60, 636–643.

  • Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA and Castellino FJ . (2000). Cancer Res., 60, 5839–5847.

  • Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, Erdreich-Epstein A and DeClerck YA . (2001). Cancer Res., 61, 5587–5594.

  • Kjoller L, Kanse SM, Kirkegaard T, Rodenburg KW, Ronne E, Goodman SL, Preissner KT, Ossowski L and Andreasen PA . (1997). Exp. Cell Res., 232, 420–429.

  • Lambert V, Munaut C, Carmeliet P, Gerard RD, Declerck PJ, Gils A, Claes C, Foidart JM, Noel A and Rakic JM . (2003). Invest Ophthalmol. Vis. Sci., 44, 2791–2797.

  • Lambert V, Munaut C, Noel A, Frankenne F, Bajou K, Gerard R, Carmeliet P, Defresne MP, Foidart JM and Rakic JM . (2001). FASEB J., 15, 1021–1027.

  • Lijnen HR, Van Hoef B, Umans K and Collen D . (2004). J. THromb. Haemost., 2, 16–22.

  • Liu G, Shuman MA and Cohen RL . (1995). Int. J. Cancer, 60, 501–506.

  • Masson V, Devy L, Grignet-Debrus C, Bernt S, Bajou K, Blacher S, Roland G, Chang Y, Fong T, Carmeliet P, Foidart JM and Noel A . (2002). Biol. Proc. Online, 4, 24–31.

  • McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC and Lawrence DA . (2001). J. Biol. Chem., 276, 33964–33968.

  • Montesano R, Pepper MS, Mohle-Steinlein U, Risau W, Wagner EF and Orci L . (1990). Cell, 62, 435–445.

  • Pepper MS and Montesano R . (1990). Cell Differ. Dev., 32, 319–327.

  • Rakic JM, Maillard C, Jost M, Bajou K, Masson V, Devy L, Lambert V, Foidart JM and Noel A . (2003). Cell Mol. Life Sci., 60, 463–473.

  • Soff GA, Sanderowitz J, Gately S, Verrusio E, Weiss I, Brem S and Kwaan HC . (1995). J. Clin. Invest., 96, 2593–2600.

  • Stefansson S, Petitclerc E, Wong MK, McMahon GA, Brooks PC and Lawrence DA . (2001). J. Biol. Chem., 276, 8135–8141.

  • Stephens RW, Brunner N, Janicke F and Schmitt M . (1998). Breast Cancer Res. Treat., 52, 99–111.

Download references

Acknowledgements

We thank Fabrice Olivier for his technical assistance. This work was supported by grants from the Communauté française de Belgique (Actions de Recherches Concertées), the Commission of European Communities (LSHC-CT-2003-503297), the Fonds National de la Recherche Scientifique (FNRS, Belgium), the Fédération Belge Contre le Cancer, the Fonds spéciaux de la Recherche (University of Liège), the Centre Anticancéreux près l'Université de Liège, the FB Assurances, the D.G.T.R.E. from the ‘Région Wallonne’, the Interuniversity Attraction Poles (I.U.A.P.) from the Federal Office for Scientific, Technical and Cultural Affairs (O.S.T.C., Brussels, Belgium).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Agnès Noel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bajou, K., Maillard, C., Jost, M. et al. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23, 6986–6990 (2004). https://doi.org/10.1038/sj.onc.1207859

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207859

Keywords

This article is cited by

Search

Quick links